Nrg Therapeutics

Developer of drugs for neurodegenerative diseases

placeCambridge, England, United Kingdom calendar_todayFounded 2018 groups5 employees language nrgtherapeutics.com

Registered entities

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 265 times.

YearFilings
20202
20223
20234
20244
20255
20263

Social engagement

Social engagement: 4.3K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Omega Funds, SV Health Investors.

Investor typeCountShare
Venture capital655%
Bank & private debt19%
Other / undisclosed436%

Recent activity

30 Jun 2026
Event
ENCALS annual meeting
19 Jun 2026
Event
BIO International Convention
28 May 2026
Event
NRG5051
Coming soon